Compare PBLS & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | TENB |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2026 | 2018 |
| Metric | PBLS | TENB |
|---|---|---|
| Price | $28.81 | $39.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $31.69 |
| AVG Volume (30 Days) | 545.1K | ★ 3.6M |
| Earning Date | N/A | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.23 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $999,405,000.00 |
| Revenue This Year | N/A | $9.37 |
| Revenue Next Year | N/A | $7.04 |
| P/E Ratio | ★ N/A | $3,991.00 |
| Revenue Growth | N/A | ★ 11.04 |
| 52 Week Low | $25.56 | $15.73 |
| 52 Week High | $33.65 | $43.67 |
| Indicator | PBLS | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 63.56 |
| Support Level | $26.96 | $25.61 |
| Resistance Level | $30.90 | N/A |
| Average True Range (ATR) | 2.39 | 2.91 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 30.56 | 68.88 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.